{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"51"}],"units":"Participants"}],"description":"Perioperative and Postoperative morbidity and mortality will be determined in patients with peritoneal carcinomatosis of colorectal, gastric, appendical, pseudomyxoma peritonei and peritoneal mesothelioma origin undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy with Mitomycin- C. The number of peri/postoperative deaths up to 30 days following the time of surgery will be recorded.","groups":[{"description":"HIPEC + 40mg of Mitomycin C. Mitomycin C, 30 mg, were administered into the inflow line of the perfusion circuit once target temperature was reached. At the 60 minute time point of the perfusion, Mitomycin C, 10 mg, was administered into the inflow line of the perfusion circuit. Once the 90-minute perfusion period had elapsed, the perfusate was drained into the waste reservoir. The peritoneal cavity was rinsed/washed-out.\n\nHIPEC\n\nMitomycin C","id":"OG000","title":"HIPEC + Mitomycin C"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"30 day Morbidity data was not collected.","reportingStatus":"POSTED","timeFrame":"Up to 30 days following surgery","title":"Perioperative and Postoperative Morbidity and Mortality","type":"PRIMARY","unitOfMeasure":"Participants"}